We reiterate our Outperform recommendation on Hanger Orthopedic (HGR). Earnings for the last quarter beat the Zacks Consensus Estimate by a penny. Top-line growth was fueled by healthy contributions from patient-care and distribution businesses and acquisitions.
Hanger is the market leader in the orthotic and prosthetic (O&P) patient care services market, operating through 678 patient care centers across the U.S. The company’s economies of scale are unmatched by its competitors. Hanger continues to pursue acquisitions to expand its geographic presence and revenues.
While costs associated with relocation are expected to dilute earnings in the third quarter, the company is poised to achieve meaningful cost synergies from such initiatives in future reporting periods.